Evaluation of YouTube As A Source For Graves' Disease Information: Is High-Quality Guideline-Based Information Available?

IF 1.8 Q2 OTORHINOLARYNGOLOGY OTO Open Pub Date : 2024-03-19 eCollection Date: 2024-01-01 DOI:10.1002/oto2.118
Oluwatobiloba Ayo-Ajibola, Ryan J Davis, Claire Theriault, Christopher Lamb, Deborah Choe, Matthew E Lin, Trevor E Angell, Daniel I Kwon
{"title":"Evaluation of YouTube As A Source For Graves' Disease Information: Is High-Quality Guideline-Based Information Available?","authors":"Oluwatobiloba Ayo-Ajibola, Ryan J Davis, Claire Theriault, Christopher Lamb, Deborah Choe, Matthew E Lin, Trevor E Angell, Daniel I Kwon","doi":"10.1002/oto2.118","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To understand the quality of informational Graves' disease (GD) videos on YouTube for treatment decision-making quality and inclusion of American Thyroid Association (ATA) treatment guidelines.</p><p><strong>Study design: </strong>Cross-sectional cohort.</p><p><strong>Setting: </strong>Informational YouTube videos with subject matter \"Graves' Disease treatment.\"</p><p><strong>Method: </strong>The top 50 videos based on our query were assessed using the DISCERN instrument. This validated algorithm discretely rates treatment-related information from excellent (≥4.5) to very poor (<1.9). Videos were also screened for ATA guideline inclusion. Descriptive statistics were used for cohort characterization. Univariate and multivariate linear regressions characterized factors associated with DISCERN scores. Significance was set at <i>P</i> < .05.</p><p><strong>Results: </strong>The videos featured 57,513.43 views (SD = 162,579.25), 1054.70 likes (SD = 2329.77), and 168.80 comments (SD = 292.97). Most were patient education (52%) or patient experience (24%). A minority (40%) were made by thyroid specialists (endocrinologists, endocrine surgeons, or otolaryngologists). Under half did not mention all 3 treatment modalities (44%), and 54% did not mention any ATA recommendations. Overall, videos displayed poor reliability (mean = 2.26, SD = 0.67), treatment information quality (mean = 2.29, SD = 0.75), and overall video quality (mean = 2.47, SD = 1.07). Physician videos were associated with lower likes, views, and comments (<i>P</i> < .001) but higher DISCERN reliability (<i>P</i> = .015) and overall score (<i>P</i> = .019). Longer videos (<i>P</i> = .015), patient accounts (<i>P</i> = .013), and patient experience (<i>P</i> = .002) were associated with lower scores.</p><p><strong>Conclusion: </strong>The most available GD treatment content on YouTube varies significantly in the quality of medical information. This may contribute to suboptimal disease understanding, especially for patients highly engaged with online health information sources.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"8 1","pages":"e118"},"PeriodicalIF":1.8000,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10949313/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"OTO Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/oto2.118","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To understand the quality of informational Graves' disease (GD) videos on YouTube for treatment decision-making quality and inclusion of American Thyroid Association (ATA) treatment guidelines.

Study design: Cross-sectional cohort.

Setting: Informational YouTube videos with subject matter "Graves' Disease treatment."

Method: The top 50 videos based on our query were assessed using the DISCERN instrument. This validated algorithm discretely rates treatment-related information from excellent (≥4.5) to very poor (<1.9). Videos were also screened for ATA guideline inclusion. Descriptive statistics were used for cohort characterization. Univariate and multivariate linear regressions characterized factors associated with DISCERN scores. Significance was set at P < .05.

Results: The videos featured 57,513.43 views (SD = 162,579.25), 1054.70 likes (SD = 2329.77), and 168.80 comments (SD = 292.97). Most were patient education (52%) or patient experience (24%). A minority (40%) were made by thyroid specialists (endocrinologists, endocrine surgeons, or otolaryngologists). Under half did not mention all 3 treatment modalities (44%), and 54% did not mention any ATA recommendations. Overall, videos displayed poor reliability (mean = 2.26, SD = 0.67), treatment information quality (mean = 2.29, SD = 0.75), and overall video quality (mean = 2.47, SD = 1.07). Physician videos were associated with lower likes, views, and comments (P < .001) but higher DISCERN reliability (P = .015) and overall score (P = .019). Longer videos (P = .015), patient accounts (P = .013), and patient experience (P = .002) were associated with lower scores.

Conclusion: The most available GD treatment content on YouTube varies significantly in the quality of medical information. This may contribute to suboptimal disease understanding, especially for patients highly engaged with online health information sources.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对 YouTube 作为巴塞杜氏病信息来源的评估:是否有基于指南的高质量信息?
目的:了解YouTube上巴塞杜氏病(GD)信息视频的质量,以确定治疗决策的质量,并纳入美国甲状腺协会(ATA)治疗指南:研究设计:横断面队列研究:横断面队列:YouTube上主题为 "巴塞杜氏病治疗 "的信息视频:使用 DISCERN 工具对我们查询的前 50 个视频进行评估。这种经过验证的算法将与治疗相关的信息从优秀(≥4.5)到极差(P)进行离散评分:视频的浏览量为 57513.43 次(SD = 162579.25),点赞数为 1054.70 次(SD = 2329.77),评论数为 168.80 次(SD = 292.97)。大部分是患者教育(52%)或患者体验(24%)。少数(40%)是由甲状腺专家(内分泌科医生、内分泌外科医生或耳鼻喉科医生)发表的。不到一半的视频没有提及所有三种治疗方式(44%),54%的视频没有提及任何ATA建议。总体而言,视频的可靠性(平均值 = 2.26,SD = 0.67)、治疗信息质量(平均值 = 2.29,SD = 0.75)和整体视频质量(平均值 = 2.47,SD = 1.07)均较差。医生视频的点讚数、浏览数和评论数(P P = .015)以及总评分(P = .019)均较低。较长的视频(P = .015)、患者账户(P = .013)和患者体验(P = .002)与较低的得分相关:结论:YouTube 上最常见的广东治疗内容在医疗信息质量方面差异很大。结论:YouTube 上最多的 GD 治疗内容在医疗信息质量方面存在很大差异,这可能会导致对疾病的理解不尽人意,尤其是对于高度使用在线健康信息来源的患者而言。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
OTO Open
OTO Open Medicine-Surgery
CiteScore
2.70
自引率
0.00%
发文量
115
审稿时长
15 weeks
期刊最新文献
Bulbar Manifestation of Myasthenia Gravis Initially Attributed to Goiter: A Case Report. Thyroid Cancer Burden in China: 1990 to 2021 Trends and 15-Year Projections Against Global Trends. Limited Utility of Existing Hearing Loss Panels in the Assessment of Early-Onset, Bilateral Meniere's Disease. Revision Flap Coverage Following Primary Cochlear Implant Flap Failure: A Systematic Review. Does Monopolar Electrosurgery Adversely Impact the Bone Conduction Hearing Implant Bonebridge?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1